Larvol Delta - BioPath-Holdings-Announces-Successful-Completion-of-Safety-Cohort-of-Triple-Combination-of-Prexigebersen-Decitabine-and-Venetoclax-in-Stage-2-of-Phase-2-Clinical-Trial-in-Acute-Myeloid-Leukemia

Venclexta (venetoclax) - Roche, AbbVie

prexigebersen (BP1001) - Bio-Path

https://www.globenewswire.com/news-release/2021/04/05/2204178/0/en/Bio-Path-Holdings-Announces-Successful-Completion-of-Safety-Cohort-of-Triple-Combination-of-Prexigebersen-Decitabine-and-Venetoclax-in-Stage-2-of-Phase-2-Clinical-Trial-in-Acute-My.html

Apr 5, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next